ClinicalTrials.gg
Drug

Fenretinide clinical trials

Also written McN-R-1967, ST-001 and N-(4-hydroxyphenyl)retinamide.

studies test it
44
open now
2
in phase 3
7
first study started
1993

How each study uses Fenretinide is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Fenretinide studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
Not in FDA's approval records
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

fenretinide
41
4-HPR
8
fenretinimide
5
LAU-7b
2

Development codes

McN-R-1967
4
ST-001
2
ISLA101
1

Other names

N-(4-hydroxyphenyl)retinamide
2

Studies by the year they started

43 studies that test it; most in 2000 (5)

Studies that test Fenretinide, by start year
YearStudies
19931
19941
19951
19961
19972
19983
19991
20005
20012
20021
20033
20042
20052
20063
20071
20091
20101
20121
20142
20162
20181
20201
20233
20241
20251

By phase

A phase 1/2 study counts in both.

Phase 1
17
Phase 2
22
Phase 3
7
No phase
2

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 9 · Other 35

National Cancer Institute (NCI) (8) · M.D. Anderson Cancer Center (4) · South Plains Oncology Consortium (4) · Laurent Pharmaceuticals Inc. (3) · Island Pharmaceuticals (2) · Eastern Cooperative Oncology Group (2) · California Cancer Consortium (2) · Barbara Ann Karmanos Cancer Institute (2)

Often tested with

Tested in the same studies.

Tamoxifen (2) · Cisplatin (2) · Paclitaxel (2) · Tretinoin (1) · Ketoconazole (1) · Vincristine (1) · Rituximab (1) · Bexarotene (1)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 1

Studies that test Fenretinide.

Studies

Open first, then newest update. How each study uses Fenretinide is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 44

See all 44 studies that test Fenretinide →

Given beside what is tested · 1 — Fenretinide is usual care or a partner of the new treatment

Codes

What other systems call Fenretinide · ClinicalTrials.gg INT008581

  • MeSH (NLM) D017313FenretinideConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) 187EJ7QEXLFENRETINIDEConfirmed FDA, NLM, Wikidata
  • RxNorm 24870One source Wikidata
  • Wikidata Q5443576fenretinideConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C1098FenretinideOne source FDA
  • DrugBank DB05076One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.